Pilot Study of NKG2D CAR-T in Treating Patients With Recurrent Glioblastoma

NCT04717999 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UWELL Biopharma